Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | HTR2A | P28223 | 5/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.32 |
| ▸ | XDH | P47989 | 1/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7080656 | 0.78 | THRA (0.42) | THRATHRBHTR2ATAAR1XDH | |
| SCHEMBL3130075 | 0.78 | THRA (0.41) | THRATHRBHTR2ATAAR1XDH | |
| SCHEMBL2778642 | 0.78 | THRA (0.47) | THRATHRBHTR2ATAAR1XDH | |
| SCHEMBL13374131 | 0.73 | THRA (0.36) | THRATHRBHTR2ATAAR1XDH | |
| SCHEMBL4622068 | 0.72 | HTR2A (0.49) | THRATHRBHTR2ATAAR1 | |
| SCHEMBL5073881 | 0.71 | THRA (0.47) | THRATHRBXDHTLR8ESR1 | |
| SCHEMBL8062744 | 0.69 | THRA (0.41) | THRATHRBHTR2ATAAR1XDH | |
| SCHEMBL8592803 | 0.69 | THRA (0.41) | THRATHRBXDHTLR8ESR1 | |
| SCHEMBL7080828 | 0.69 | THRA (0.41) | THRATHRBHTR2ATAAR1XDH | |
| SCHEMBL12892623 | 0.67 | TAAR1 (0.49) | HTR2ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8288542-B2 | Noble ruthenium-type sensitizer and method of preparing the same | DONGJIN SEMICHEM CO., LTD. (KR) | 2012-10-16 | — | — | US | disclosed |
| US-20100071763-A1 | NOBLE RUTHENIUM-TYPE SENSITIZER AND METHOD OF PREPARING THE SAME | DONGJIN SEMICHEM CO., LTD. (KR) | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100071763-A1 | NOBLE RUTHENIUM-TYPE SENSITIZER AND METHOD OF PREPARING THE SAME | MSH6, CRY1, MKI67 | THRA 4334/4885THRB 4426/4885HTR2A 4708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.